Final Results From A Phase I Trial And Expansion Cohorts Of Cabozantinib And Nivolumab (Cabonivo) Alone Or With Ipilimumab (Cabonivoipi) For Metastatic Genitourinary Tumors.

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 7|浏览32

暂无评分

摘要

3Background: CaboNivo and CaboNivoIpi showed promising efficacy and safety in a dose-escalation phase I study in patients (pts) with metastatic genitourinary (mGU) tumors. We now report the final r...

查看译文

关键词

Nivolumab,Ipilimumab,Cabozantinib,Genitourinary system,Oncology,Medicine,In patient,Internal medicine,Phase i study

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要